Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project
- PMID: 29768114
- DOI: 10.1089/jwh.2017.6730
Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project
Abstract
Objective: We sought to evaluate whether differences in rates of contraceptive discontinuation exist among black and white women receiving contraceptive counseling and no-cost contraception among users of long-acting reversible contraceptive (LARC; intrauterine devices or subdermal implant) and non-LARC (oral contraceptive pills, contraceptive vaginal ring, patch, or injection) methods.
Materials and methods: We analyzed data from a prospective cohort study of 7546 non-Hispanic black and white women who participated in the Contraceptive CHOICE Project. Among women who initiated their method within 12 weeks of enrollment, discontinuation was defined as any break in use longer than 1 month. Using Cox proportional hazards regression analysis, we estimated discontinuation stratified by use of LARC methods.
Results: There were no statistically significant differences in contraceptive discontinuation between black and white women at 12, 24, or 36 months among both LARC [12-month adjusted hazard ratio (HRadj-12M) 1.01 (95% confidence interval or 95% CI 0.86-1.18); HRadj-24M 1.10 (95% CI 0.97-1.24); and HRadj-36M 1.10 (95% CI 0.98-1.23)] and non-LARC users [HRadj-12M 1.08 (95% CI 0.92, 1.26); HRadj-24M 1.07 (95% CI 0.94, 1.23); and HRadj-36M 1.08 (95% CI 0.95, 1.23)] adjusting for confounders. Secondary analyses found no significant differences in discontinuation of LARC and non-LARC methods among black and white women at highest risk of pregnancy or those receiving public assistance at baseline.
Conclusions: At 12, 24, and 36 months there were no differences in contraceptive discontinuation of both LARC methods and non-LARC methods when comparing white and black women.
Keywords: discontinuation; family planning; long-acting reversible contraception; race.
Similar articles
-
Contraceptive continuation in Hispanic women.Am J Obstet Gynecol. 2015 Mar;212(3):312.e1-8. doi: 10.1016/j.ajog.2014.09.003. Epub 2014 Sep 9. Am J Obstet Gynecol. 2015. PMID: 25218956
-
Three-year continuation of reversible contraception.Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8. doi: 10.1016/j.ajog.2015.08.001. Epub 2015 Aug 7. Am J Obstet Gynecol. 2015. PMID: 26259905 Free PMC article.
-
Twenty-four-month continuation of reversible contraception.Obstet Gynecol. 2013 Nov;122(5):1083-1091. doi: 10.1097/AOG.0b013e3182a91f45. Obstet Gynecol. 2013. PMID: 24104781 Free PMC article.
-
Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.Eur J Contracept Reprod Health Care. 2020 Dec;25(6):492-501. doi: 10.1080/13625187.2020.1833187. Eur J Contracept Reprod Health Care. 2020. PMID: 33140990
-
Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.Cochrane Database Syst Rev. 2019 Apr 23;4(4):CD004317. doi: 10.1002/14651858.CD004317.pub5. Cochrane Database Syst Rev. 2019. PMID: 31013349 Free PMC article.
Cited by
-
Family planning needs of young adults with sickle cell disease.EJHaem. 2023 May 17;4(3):587-594. doi: 10.1002/jha2.711. eCollection 2023 Aug. EJHaem. 2023. PMID: 37601884 Free PMC article.
-
Women with sickle cell disease report low knowledge and use of long acting reversible contraception.J Natl Med Assoc. 2021 Oct;113(5):552-559. doi: 10.1016/j.jnma.2021.05.005. Epub 2021 Jun 10. J Natl Med Assoc. 2021. PMID: 34119338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical